These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 18814866

  • 1. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
    Justinova Z, Mangieri RA, Bortolato M, Chefer SI, Mukhin AG, Clapper JR, King AR, Redhi GH, Yasar S, Piomelli D, Goldberg SR.
    Biol Psychiatry; 2008 Dec 01; 64(11):930-7. PubMed ID: 18814866
    [Abstract] [Full Text] [Related]

  • 2. Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.
    Schindler CW, Scherma M, Redhi GH, Vadivel SK, Makriyannis A, Goldberg SR, Justinova Z.
    Psychopharmacology (Berl); 2016 May 01; 233(10):1867-77. PubMed ID: 26803499
    [Abstract] [Full Text] [Related]

  • 3. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R.
    Psychopharmacology (Berl); 2008 Jul 01; 198(4):449-60. PubMed ID: 18446329
    [Abstract] [Full Text] [Related]

  • 4. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan 01; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 5. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2008 Dec 14; 600(1-3):50-8. PubMed ID: 18762181
    [Abstract] [Full Text] [Related]

  • 6. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M, Tanda G, Justinova Z, Wertheim CE, Yasar S, Piomelli D, Vadivel SK, Makriyannis A, Goldberg SR.
    J Pharmacol Exp Ther; 2007 Apr 14; 321(1):370-80. PubMed ID: 17210800
    [Abstract] [Full Text] [Related]

  • 7. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM, Vann RE, Wiley JL.
    Neuropharmacology; 2015 Jun 14; 93():237-42. PubMed ID: 25698527
    [Abstract] [Full Text] [Related]

  • 8. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW, Thorpe AJ, Schlosburg JE, Cravatt BF, Abdullah RA, Smith TH, Selley DE, Lichtman AH, Sim-Selley LJ.
    Neuropsychopharmacology; 2010 Jul 14; 35(8):1775-87. PubMed ID: 20357755
    [Abstract] [Full Text] [Related]

  • 9. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
    Kangas BD, Leonard MZ, Shukla VG, Alapafuja SO, Nikas SP, Makriyannis A, Bergman J.
    J Pharmacol Exp Ther; 2016 Apr 14; 357(1):125-33. PubMed ID: 26826191
    [Abstract] [Full Text] [Related]

  • 10. The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats.
    Adamczyk P, McCreary AC, Przegalinski E, Mierzejewski P, Bienkowski P, Filip M.
    J Physiol Pharmacol; 2009 Sep 14; 60(3):119-25. PubMed ID: 19826190
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    J Pharmacol Exp Ther; 2005 Apr 14; 313(1):352-8. PubMed ID: 15579492
    [Abstract] [Full Text] [Related]

  • 12. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
    Ho WS, Randall MD.
    Br J Pharmacol; 2007 Mar 14; 150(5):641-51. PubMed ID: 17245358
    [Abstract] [Full Text] [Related]

  • 13. Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse.
    Justinova Z, Panlilio LV, Moreno-Sanz G, Redhi GH, Auber A, Secci ME, Mascia P, Bandiera T, Armirotti A, Bertorelli R, Chefer SI, Barnes C, Yasar S, Piomelli D, Goldberg SR.
    Neuropsychopharmacology; 2015 Aug 14; 40(9):2185-97. PubMed ID: 25754762
    [Abstract] [Full Text] [Related]

  • 14. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.
    Justinová Z, Ferré S, Redhi GH, Mascia P, Stroik J, Quarta D, Yasar S, Müller CE, Franco R, Goldberg SR.
    Addict Biol; 2011 Jul 14; 16(3):405-15. PubMed ID: 21054689
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.
    Scherma M, Panlilio LV, Fadda P, Fattore L, Gamaleddin I, Le Foll B, Justinová Z, Mikics E, Haller J, Medalie J, Stroik J, Barnes C, Yasar S, Tanda G, Piomelli D, Fratta W, Goldberg SR.
    J Pharmacol Exp Ther; 2008 Nov 14; 327(2):482-90. PubMed ID: 18725543
    [Abstract] [Full Text] [Related]

  • 16. The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys.
    Justinova Z, Solinas M, Tanda G, Redhi GH, Goldberg SR.
    J Neurosci; 2005 Jun 08; 25(23):5645-50. PubMed ID: 15944392
    [Abstract] [Full Text] [Related]

  • 17. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM, Guindon J, Hohmann AG.
    Pharmacol Res; 2010 Sep 08; 62(3):249-58. PubMed ID: 20416378
    [Abstract] [Full Text] [Related]

  • 18. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S, Nomikos GG, Panagis G.
    Psychopharmacology (Berl); 2006 Oct 08; 188(3):293-305. PubMed ID: 16953388
    [Abstract] [Full Text] [Related]

  • 19. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.
    Wiley JL, Walentiny DM, Wright MJ, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE.
    Eur J Pharmacol; 2014 Aug 15; 737():97-105. PubMed ID: 24858366
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B.
    Psychopharmacology (Berl); 2016 May 15; 233(10):1823-8. PubMed ID: 26864774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.